breathe ilo
The company provides a Class I medical device and mobile application that tracks a woman's menstrual cycle and fertile window by measuring CO2 levels in breath. This 60-second daily test identifies hormonal shifts to predict ovulation up to six days in advance, serving women who are trying to conceive or seeking to understand their hormonal health. Now part of the MAM Baby AG group, the technology replaces traditional methods like temperature tracking or urine tests with a non-invasive respiratory measurement.
Funding summary
- Total raised
- €3.0M
- Funding rounds
- 1
Investors in breathe ilo
Investors on record for breathe ilo. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like breathe ilo?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors